Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazyar Shadman

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
Circulation|May 4, 2011
Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillationAyman A Hussein, Walid I Saliba, David O Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Journal for Immunotherapy of Cancer|January 22, 2024
CD8<sup>+</sup> chimeric antigen receptor T cells manufactured in absence of CD4<sup>+</sup> cells exhibit hypofunctional phenotypeSang Yun Lee, Dong Hoon Lee, Wei Sun, et al.
Blood Advances|June 28, 2023
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphomaW Richard Burack, Hongli Li, Diana Adlowitz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 11, 2026
Biomarkers Informed by Single-Cell and Spatial Transcriptomics - Biomarkers for Grade 3 Follicular LymphomaAarti Kanzaria, Sonali Arora, Anisha Naik, et al.
Blood Cancer Journal|June 18, 2026
Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphomaJohn Sharp, Subodh Bhatta, Jennifer J Huang, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell LymphomaCarrie Ho, Neena Kennedy, Mengyang Di, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
Blood Advances|May 7, 2025
Zanubrutinib is well tolerated and effective in CLL/SLL patients intolerant of ibrutinib/acalabrutinib: Updated resultsMazyar Shadman, John M Burke, Jennifer Cultrera, et al.
Haematologica|June 19, 2025
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myelomaAndrew J Portuguese, Emily C Liang, Jennifer J Huang, et al.
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
Circulation|May 4, 2011
Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillationAyman A Hussein, Walid I Saliba, David O Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Journal for Immunotherapy of Cancer|January 22, 2024
CD8<sup>+</sup> chimeric antigen receptor T cells manufactured in absence of CD4<sup>+</sup> cells exhibit hypofunctional phenotypeSang Yun Lee, Dong Hoon Lee, Wei Sun, et al.
Blood Advances|June 28, 2023
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphomaW Richard Burack, Hongli Li, Diana Adlowitz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 11, 2026
Biomarkers Informed by Single-Cell and Spatial Transcriptomics - Biomarkers for Grade 3 Follicular LymphomaAarti Kanzaria, Sonali Arora, Anisha Naik, et al.
Blood Cancer Journal|June 18, 2026
Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphomaJohn Sharp, Subodh Bhatta, Jennifer J Huang, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell LymphomaCarrie Ho, Neena Kennedy, Mengyang Di, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
Blood Advances|May 7, 2025
Zanubrutinib is well tolerated and effective in CLL/SLL patients intolerant of ibrutinib/acalabrutinib: Updated resultsMazyar Shadman, John M Burke, Jennifer Cultrera, et al.
Haematologica|June 19, 2025
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myelomaAndrew J Portuguese, Emily C Liang, Jennifer J Huang, et al.
Pageof 23